(2S,5S,8S,15S,22S,29S)-methyl 2-amino-29-((2S,5S,8S,15S,22S)-2-amino-15-((S)-2-((S)-2-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-hydroxypropanamido)-4-methylpentanamido)-22-((S)-2,6-bis((S)-2-((S)-2-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-hydroxypropanamido)-4-methylpentanamido)hexanamido)-5-(hydroxymethyl)-1-(4-hydroxyphenyl)-8-isobutyl-3,6,9,16-tetraoxo-4,7,10,17-tetraazatricosanamido)-15-((S)-2-((S)-2-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-hydroxypropanamido)-4-methylpentanamido)-22-((S)-2,6-bis((S)-2-((S)-2-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-hydroxypropanamido)-4-methylpentanamido)hexanamido)-5-(hydroxymethyl)-1-(4-hydroxyphenyl)-8-isobutyl-3,6,9,16,23-pentaoxo-4,7,10,17,24-pentaazatriacontan-30-oate

ID: ALA4542382

Chembl Id: CHEMBL4542382

PubChem CID: 155551445

Max Phase: Preclinical

Molecular Formula: C187H288N38O48

Molecular Weight: 3836.58

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)[C@H](CCCCNC(=O)[C@H](CCCCNC(=O)[C@H](CCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)NC(=O)[C@H](CCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)NC(=O)[C@H](CCCCNC(=O)[C@H](CCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)NC(=O)[C@H](CCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1

Standard InChI:  InChI=1S/C187H288N38O48/c1-102(2)78-141(210-179(264)149(94-226)218-157(242)126(188)86-110-39-55-118(234)56-40-110)168(253)199-74-26-19-33-135(204-175(260)145(82-106(9)10)214-183(268)153(98-230)222-161(246)130(192)90-114-47-63-122(238)64-48-114)166(251)196-71-25-18-32-134(203-172(257)137(207-177(262)147(84-108(13)14)216-185(270)155(100-232)224-163(248)132(194)92-116-51-67-124(240)68-52-116)35-22-29-76-201-170(255)143(80-104(5)6)212-181(266)151(96-228)220-159(244)128(190)88-112-43-59-120(236)60-44-112)165(250)198-73-31-24-38-140(187(272)273-17)209-174(259)139(206-173(258)138(208-178(263)148(85-109(15)16)217-186(271)156(101-233)225-164(249)133(195)93-117-53-69-125(241)70-54-117)36-23-30-77-202-171(256)144(81-105(7)8)213-182(267)152(97-229)221-160(245)129(191)89-113-45-61-121(237)62-46-113)37-21-28-72-197-167(252)136(205-176(261)146(83-107(11)12)215-184(269)154(99-231)223-162(247)131(193)91-115-49-65-123(239)66-50-115)34-20-27-75-200-169(254)142(79-103(3)4)211-180(265)150(95-227)219-158(243)127(189)87-111-41-57-119(235)58-42-111/h39-70,102-109,126-156,226-241H,18-38,71-101,188-195H2,1-17H3,(H,196,251)(H,197,252)(H,198,250)(H,199,253)(H,200,254)(H,201,255)(H,202,256)(H,203,257)(H,204,260)(H,205,261)(H,206,258)(H,207,262)(H,208,263)(H,209,259)(H,210,264)(H,211,265)(H,212,266)(H,213,267)(H,214,268)(H,215,269)(H,216,270)(H,217,271)(H,218,242)(H,219,243)(H,220,244)(H,221,245)(H,222,246)(H,223,247)(H,224,248)(H,225,249)/t126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-/m0/s1

Standard InChI Key:  IXSKFBOCLOHUIN-UNGQIMBNSA-N

Alternative Forms

  1. Parent:

    ALA4542382

    ---

Associated Targets(non-human)

4T1 (1737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 3836.58Molecular Weight (Monoisotopic): 3834.1263AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Zhang Z, Li Y, Wu H, Zhang X, Zhong D, Wu Y, Xu X, Yang J, Gu Z..  (2019)  Inhibitory Effects of Multivalent Polypeptides on the Proliferation and Metastasis of Breast Cancer Cells.,  10  (12): [PMID:31857837] [10.1021/acsmedchemlett.9b00339]

Source